🇺🇸 FDA
Patent

US 7008940

Dihydrobenzofuran derivatives, process for the preparing thereof and agents

expired A61PA61P13/02A61P25/00

Quick answer

US patent 7008940 (Dihydrobenzofuran derivatives, process for the preparing thereof and agents) held by Takeda Pharmaceutical Company Limited expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P13/02, A61P25/00, A61P25/16, A61P25/28